Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | THPO | P40225 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.55 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.38 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2352537 | 1.00 | KDM4E (0.67) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Hydrochloric Acid SCHEMBL28494459 | 0.97 | KDM4E (0.64) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Hydrochloric Acid SCHEMBL28494458 | 0.97 | KDM4E (0.64) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL4984856 | 0.84 | KDM4E (0.67) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL1289325 | 0.80 | KDM4E (0.61) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL5292 | 0.80 | MAPT (1.00) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL5291 | 0.80 | MAPT (1.00) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL3688241 | 0.80 | MAPT (1.00) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL4990899 | 0.80 | KDM4E (0.61) | KDM4EMAPTTHRBALOX15NFKB1 | |
| Acetylcysteine SCHEMBL149212 | 0.80 | MAPT (1.00) | KDM4EMAPTTHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114615997-A | Pharmaceutical compositions comprising cannabinoids | 黑鹰有限合伙公司 | 2022-06-10 | — | — | CN | claimed |
| EP-3952670-A1 | A HIGHLY AVAILABLE POWDER COMPOSITION CONTAINING RED RICE | Pharmanutrition R&D S.r.l. (IT) | 2022-02-16 | — | — | EP | claimed |
| CN-112321579-A | Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2 (1H) -one derivatives | 阿尔米雷尔有限公司 | 2021-02-05 | — | — | CN | claimed |
| WO-2020208404-A1 | A HIGHLY AVAILABLE POWDER COMPOSITION CONTAINING RED RICE | Pharmanutrition R&D S.r.l. (IT) | 2020-10-15 | — | — | WO | claimed |
| CN-106456781-B | Hydroalcoholic system for nail treatment | 圣地亚哥-德孔波斯特拉大学 | 2020-07-10 | — | — | CN | claimed |
| US-20250319050-A1 | PHARMACEUTICAL FORMULATION | RB HEALTH US LLC (US) | 2025-10-16 | — | — | US | disclosed |
| CN-113365513-B | Compositions and methods for treating lung | G·E·霍格 | 2025-04-25 | — | — | CN | disclosed |
| US-12257218-B2 | Pharmaceutical formulation | RB HEALTH (US) LLC (US) | 2025-03-25 | — | — | US | disclosed |
| CN-119212693-A | Combination of taurine glycol and sodium phenylbutyrate for the treatment of amyotrophic lateral sclerosis | 艾米利克斯制药公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119156207-A | Methods and compositions for treating amyotrophic lateral sclerosis | 艾米利克斯制药公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119136793-A | Bile acids and phenylbutyric acid with CYP P450 or transporter substrates for the treatment of amyotrophic lateral sclerosis | 艾米利克斯制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118949048-A | Composition of bile acid and phenylbutyric acid compound | 艾米利克斯制药公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20170100355-A1 | PHARMACEUTICAL FORMULATION | RB HEALTH (US) LLC | 2017-04-13 | — | — | US | disclosed |
| EP-2360195-B1 | PHOTO-CURING MATERIAL MANUFACTURING METHOD, AND PHOTO-CURING MATERIAL AND ARTICLE | ASAHI GLASS CO LTD (JP) | 2013-02-20 | — | — | EP | disclosed |
| US-8207242-B2 | Process for producing photocurable material, photocurable material and article | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20110237703-A1 | PROCESS FOR PRODUCING PHOTOCURABLE MATERIAL, PHOTOCURABLE MATERIAL AND ARTICLE | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2360195-A1 | PHOTO-CURING MATERIAL MANUFACTURING METHOD, AND PHOTO-CURING MATERIAL AND ARTICLE | Asahi Glass Company Limited (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-7329536-B2 | Piezoimmunosensor | OAKLAND UNIVERSITY (US) | 2008-02-12 | — | — | US | disclosed |
| WO-2005001421-A2 | IMPROVED PIEZOIMMUNOSENSOR | OAKLAND UNIVERSITY (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20050003560-A1 | Piezoimmunosensor | OAKLAND UNIVESITY (US) | 2005-01-06 | — | — | US | disclosed |